The diabetes management platform developer has now received $27m in total funding, after raising $16m from backers including Samsung and Medtronic.
Glooko, the US-based manufacturer of a remote diabetes patient monitoring system, obtained $16.5m yesterday in a series B round featuring consumer electronics company Samsung and medical device maker Medtronic.
Venture capital firms Canaan Partners and Social + Capital Partnership also took part in the round.
Glooko closed its series A round at $10.5m in January 2014, having received the initial $3.5m tranche in 2012. The series A funding came from Samsung, Social + Capital, Lifeforce Ventures, Xtreme Labs and a…